What is a Whole Exome Analysis? Here, we review the feasibility of WES of cfDNA and determine the sensitivity of WES-detected single nucleotide variants (SNVs) in cfDNA on individual patient data level using paired tumor tissue as reference (sharedSNVsAlltissueSNVs×100%). Utility of Circulating Tumor DNA for Detection and Monitoring of Endometrial Cancer Recurrence and Progression. Paramount applies coding edits to all medical claims through coding logic software Thank you for your comments. Whole exome sequencing revealed a homozygous p.Gly218Ser variation in TGM1; a variation reported earlier in an isolated Finnish population in association with autosomal recessive non-syndromic ichthyosis. GCTs are derived from S... Whole‐exome sequencing reveals novel vacuolar ATPase genes’ variants and variants in genes involved in lysosomal biology and autophagosomal formation in oral granular cell tumors - França - - Journal of Oral Pathology & Medicine - Wiley Online Library Skip to Article Content Skip to Article Information  |  With high-precision reporting, detailed analysis and easy-to-read reports, this service empowers you to make the right decisions for diagnosis and/or treatment. The human exome represents less than 2% of the genome, but contains ~85% of known disease-related variants, 1 making this method a cost-effective alternative to whole-genome sequencing. Toma C, Díaz-Gay M, Franch-Expósito S, Arnau-Collell C, Overs B, Muñoz J, Bonjoch L, Soares de Lima Y, Ocaña T, Cuatrecasas M, Castells A, Bujanda L, Balaguer F, Cubiella J, Caldés T, Fullerton JM, Castellví-Bel S. Int J Cancer. 2020 Oct 22;23(11):101661. doi: 10.1016/j.isci.2020.101661. 2020 Dec 17;12(12):3804. doi: 10.3390/cancers12123804. A homozygous variant, of uncertain significance, Asp355Tyr in the HJV gene, associated with juvenile hemochromatosis was found. Dante Labs Whole Genome Sequencing Review Whole Genome Sequencing (WGS) based on next-generation sequencing technology is the new gold standard for genetic testing. iScience. Published by Elsevier Ltd.. All rights reserved. The pooled sensitivity was 50% (95% credible interval (CI): 29-72%). Pre- and post-analytical procedures were highly variable between studies rendering comparisons problematic. 2018 Mar;57(3):123-139. doi: 10.1002/gcc.22517. Whole-exome sequencing is a widely used next-generation sequencing (NGS) method that involves sequencing the protein-coding regions of the genome. While whole exome sequencing demonstrates some advantages over microarray-based genotyping for clinical analysis of disease risk, it also has limitations. Exome sequencing, also known as whole exome sequencing (WES), is a genomic technique for sequencing all of the protein-coding regions of genes in a genome (known as the exome). These pieces, called exons, are thought to make up 1 percent of a person's genome. In conclusion, various aspects of WES of cfDNA are largely in its investigative phase, standardization of methodologies is highly needed to bring this promising technique to its clinical potential. Here, we develop a genotype calling pipeline named WEScall to analyse both target and off-target data. It is designed to examine all the coding regions and splice junctions of the genome. J Transl Med. Cancers (Basel). Whole-exome sequencing has proven to be 77valuable for identifying mutations responsible for monogenic diseases and emerging 78reports show that exome sequencing can also be applied to uncover variation associated 79with complex human traits [12, 13]. This review highlights the importance of establishing consensus on standards for the application and reporting of variants filtering strategies. Whole exome sequencing showed no known pathogenic variants in genes associated with hemochromatosis (HFE, HJV, SLC40A1, TFR2, FTH1, HAMP, SKIV2L, TTC37, and BMP2). Epub 2017 Nov 30. after excluding secondary causes. However to what extent cfDNA reflects the full metastatic landscape as currently determined by tumor tissue analysis remains controversial. Since whole exome sequencing decodes only 1% of the genome, it fails to analyze the other 99%, including structural and non-coding regions. With whole exome sequencing, that can change during the investigation.  |  Family studies to find rare high risk variants in migraine.  |  Non-coding regions, typically covered by sparse off-target data, are often discarded by conventional WES analyses. 2017 Nov 21;12(11):e0188174. BMC Cancer. Detection of ubiquitous and heterogeneous mutations in cell-free DNA from patients with early-stage non-small-cell lung cancer. COVID-19 is an emerging, rapidly evolving situation. This short animated video tells the story of Jimmy, a young boy with specific health and developmental difficulties. 2017 Dec;18(1):32. doi: 10.1186/s10194-017-0729-y. The overall agreement (sharedSNVsAllSNVs×100%)between SNVs in cfDNA and tumor tissue was 31% (95% CI: 15-49%). 2019 Aug 7;19(1):783. doi: 10.1186/s12885-019-5994-5. Molecular profiling of tumor derived cell free DNA (cfDNA) is gaining ground as a prognostic and predictive biomarker. Please enable it to take advantage of the complete set of features! Epub 2016 Jun 27. Strikingly, more than a quarter of all known genes related to NSHL were discovered in the past 5 years via NGS technologies. The use of clinical genome and exome sequencing for genetic diagnosis has grown substantially. Though technically challenging, whole exome sequencing (WES) of cfDNA enables thorough evaluation of somatic alterations. Whole exome sequencing (WES) is a molecular genetic process that can be used to identify alternations in genes. NLM This site needs JavaScript to work properly. Would you like email updates of new search results? HHS Then, too, “Some targeted panels are getting CPT codes. A Systematic Literature Review of Whole Exome and Genome Sequencing Population Studies of Genetic Susceptibility to Cancer A Systematic Literature Review of Whole Exome and Genome Sequencing Population Studies of Genetic Susceptibility to Cancer Cancer Epidemiol Biomarkers Prev. We conducted a systematic literature review of cancer genetic susceptibility studies that used NGS technologies at an exome/genome-wide scale to obtain a fuller understanding of the research landscape to date and to inform future studies. WES refers to the sequence determination of the exome.  |  Whole exome sequencing, also called exome sequencing, is a testing strategy to selectively look at only the protein-coding gene regions (i.e., exons) of a genome.  |  The application of next-generation sequencing (NGS) technologies in cancer research has accelerated the discovery of somatic mutations; however, progress in the identification of germline variation associated with cancer risk is less clear. which perform important functions within a cell. This method allows variations in the protein-coding region of any gene to be identified, rather than in only a select few genes. Hum Mutat. It also describes the progress in the identification of cancer-related germline variation to date. Keywords: Nonetheless, it has the characteristics of big data in large deployment. TÜM EKZOM DİZİLEME (WHOLE EXOME SEQUENCING – WES TEST) Genler, DNA üzerinde bulunan ve proteinlerin kodlanmasından sorumlu olan bölgelerdir. 2018 Feb 15;24(4):939-949. doi: 10.1158/1078-0432.CCR-17-1586. Proteinlerin yapımı sırasında intron bölgeleri çıkarılır … Market growth attributes to the rising usage of exome in the identification … Whole exome sequencing for the diagnosis of phenotypic disorder patients was utilized in a study of 250 unselected, referred patients who had previously undergone extensive rare genetic disease diagnostic testing, with a 24.8% (62/250) molecular diagnosis rate of autosomal dominant (n = 33), autosomal recessive (n = 16), and X-linked (n = 9) diseases.  |  2016 Sep;37(9):835-46. doi: 10.1002/humu.23017. 2016 May;27(5):862-7. doi: 10.1093/annonc/mdw037. Next Generation Sequencing-Based Profiling of Cell Free DNA in Patients with Advanced Non-Small Cell Lung Cancer: Advantages and Pitfalls. This method is relatively new, and as the technology advances rapidly, further research and the discovery of more practical clinical purposes are expected to emerge. De novo mutation … Family specific genetic predisposition to breast cancer: results from Tunisian whole exome sequenced breast cancer cases. ©2020 American Association for Cancer Research. Several reviews have described the sequencing technology platforms and advancements made in next-generation sequencing (NGS) over the past decade . As per Market Research Future (MRFR) analysis, the global whole exome sequencing market is estimated to reach USD 2,696.03 million with a CAGR of 19.80% from 2019 to 2025 (forecast period). Her genin içinde ise, ekzon ve intron denilen alt bölgeler bulunur. The tissue mutant allele frequency (MAF) of variants exclusively identified in tissue was significantly lower (12.5%, range: 0.5-18%) than the tissue MAF of variants identified in both tissue and cfDNA (23.9%, range: 17-38%), p = 0.004. Results: One patient with hemochromatosis had a homozygous HFE gene C282Y Whole Exome Sequencing (WES) is an efficient strategy to selectively sequence the coding regions (exons) of a genome, typically human, to discover rare or common variants associated with a disorder or phenotype [1, 2]. J Headache Pain. Copyright © 2019 The Author(s). National Center for Biotechnology Information, Unable to load your collection due to an error, Unable to load your delegates due to an error. Whole Genome Sequencing (WGS) as part of the assessment in addition to Whole Exome Sequencing (WES). Here, we review the feasibility of WES of cfDNA and determine the sensitivity of WES-detected single nucleotide variants (SNVs) in cfDNA on individual patient data level using paired tumor tissue as reference (sharedSNVsAlltissueSNVs×100%). 2020 Mar 15;146(6):1568-1577. doi: 10.1002/ijc.32683. Though technically challenging, whole exome sequencing (WES) of cfDNA enables thorough evaluation of somatic alterations. Using linkage studies combined with whole-exome sequencing to identify novel candidate genes for familial colorectal cancer. Comment 2: Suggest that Key The number of detected SNVs was positively correlated with circulating tumor DNA (ctDNA) fraction (p = 0.016). eCollection 2017. NIH Whole exome sequencing for determination of tumor mutation load in liquid biopsy from advanced cancer patients. Koeppel F, Blanchard S, Jovelet C, Genin B, Marcaillou C, Martin E, Rouleau E, Solary E, Soria JC, André F, Lacroix L. PLoS One. Approaching Cancer Evolution from Different Angles. HHS This concurrence of a potentially benign 22q12+ duplication and LI, both rare individually, is reported here likely for the first time. Whole Exome Sequencing (WES) and Whole Genome Sequencing (WGS) Policy Number: PG0468 Last Review: 04/01/2020 GUIDELINES This policy does not certify benefits or authorization of benefits, which is designated by each individual policyholder contract. Epub 2017 Dec 20. Whole-Exome Sequencing: Technical Details Jim Mullikin Director, NIH Intramural Sequencing Center Head, Comparative Genomics Unit Whole Exome Sequencing, Why? It consists of two steps: the first step is to select only the subset of DNA that encodes proteins. Most studies sequenced few high-risk (mainly European) families, used a candidate analysis approach, and identified potential cancer-related germline variants or genes in a small fraction of the sequenced cancer cases. Epub 2017 Mar 2. Non-blood sources of cell-free DNA for cancer molecular profiling in clinical pathology and oncology. National Center for Biotechnology Information, Unable to load your collection due to an error, Unable to load your delegates due to an error. Crit Rev Oncol Hematol. Earn 100points for writing a review for this product Mapmygenome now offers Exome Sequencing for genetic diagnosis and clinical interpretation. Exome and targeted sequencing provide a balance between cost and benefit, in contrast to whole genome sequencing (WGS). As one of the widely used targeted sequencing method, whole-exome sequencing (WES) has become more and more popular in clinical and basic research. Beckett’s genome was sequenced by the HudsonAlpha Institute of Biotechnology in Alabama, where a study is under way to compare exome and genome sequencing. •Focuses on the part of the genome we understand best, the exons of genes •Exomes are ideal to help us understand high-penetrance allelic variation and its relationship to phenotype. In this article, we review recent developments in the usage of NGS for hereditary deafness, with an emphasis on whole-exome sequencing. Most DNA testing companies such as 23andMe and Ancestry analyze only a … This site needs JavaScript to work properly. This method can be used to identify variations in the protein-coding region of any gene, rather than in only a select few genes. Whole Exome Sequencing (WES), sequences the complete coding region of the genome. Clipboard, Search History, and several other advanced features are temporarily unavailable. Moss EL, Gorsia DN, Collins A, Sandhu P, Foreman N, Gore A, Wood J, Kent C, Silcock L, Guttery DS. WGS was considered but determined by the HCA to be beyond the scope of the policy goals and questions not be relevant to the policy context in the state at this time. The Roche/NimbleGen whole-exome array capture protocols were developed for DNA sequencing on the 454 platform ; because the cost of sequencing on the Illumina platform is potentially considerably lower, we adapted hybrid capture using the NimbleGen 2.1M Human Exome Array to the Illumina DNA sequencing platform (see Methods). A sub analysis of samples with ctDNA fractions ≥ 25% improved the sensitivity to 69% (95% CI: 46-89%) and agreement to 46% (95% CI: 36-59%), suggesting that WES is mainly feasible for patients with high ctDNA fractions. 2020 Aug 10;12(8):2231. doi: 10.3390/cancers12082231. Whole exome sequencing (WES) targets approximately 3% of the whole genome, which is the basis for protein-coding genes. Whole Exome Sequencing 2 June 2017 “Genomic Micro‐array and Whole Exome Sequencing” topic proposed by the HCA Director September 2017 WES affirmed as out‐of‐scope. Would you like email updates of new search results? 2018 Jun 7;16(1):158. doi: 10.1186/s12967-018-1504-9. Get the latest public health information from CDC: https://www.coronavirus.gov, Get the latest research information from NIH: https://www.nih.gov/coronavirus, Find NCBI SARS-CoV-2 literature, sequence, and clinical content: https://www.ncbi.nlm.nih.gov/sars-cov-2/. USA.gov. COVID-19 is an emerging, rapidly evolving situation. Whole Genome Sequencing (WGS) and Whole Exome Sequencing (WES) are increasingly clinically available due to significant advances in DNA sequencing technology over the last several years (Taber et al., 2014). Clipboard, Search History, and several other advanced features are temporarily unavailable. Bayesian meta-analysis; Cancer; Cell-free DNA; Liquid biopsy; Whole exome sequencing. Exome sequencing can be used to identify disease-causing DNA variations or mutations within or near the regions of the Together, all the exons in a genome are known as the exome, and the method of sequencing them is known as whole exome sequencing. NLM These findings point to the untapped potential in conducting studies with appropriately sized and racially diverse families and populations, combining results across studies and expanding beyond a candidate analysis approach to advance the discovery of genetic variation that accounts for the unexplained cancer heritability. 2019 Sep;141:36-42. doi: 10.1016/j.critrevonc.2019.06.005. Get the latest public health information from CDC: https://www.coronavirus.gov, Get the latest research information from NIH: https://www.nih.gov/coronavirus, Find NCBI SARS-CoV-2 literature, sequence, and clinical content: https://www.ncbi.nlm.nih.gov/sars-cov-2/. Chicard M, Colmet-Daage L, Clement N, Danzon A, Bohec M, Bernard V, Baulande S, Bellini A, Deveau P, Pierron G, Lapouble E, Janoueix-Lerosey I, Peuchmaur M, Corradini N, Defachelles AS, Valteau-Couanet D, Michon J, Combaret V, Delattre O, Schleiermacher G. Clin Cancer Res. Duplication and LI, both rare individually, is reported here likely the! Named WEScall to analyse both target and off-target data, are often discarded conventional. Jim Mullikin Director, NIH Intramural sequencing Center Head, Comparative Genomics Unit whole exome sequencing for diagnosis... Technology platforms and advancements made in next-generation sequencing ( WGS ) as of! ):158. doi: 10.1186/s10194-017-0729-y Treatment-Resistant Clones in Neuroblastoma between cost and benefit, in contrast to whole sequencing! 1 percent of a potentially benign 22q12+ duplication and LI, both rare individually, is reported likely! And benefit, in contrast to whole exome sequencing market is growing at a rapid pace discovered in the 5! Biopsy ; whole exome sequencing ( WES ) has been widely used next-generation sequencing WGS. Ekzon ve intron denilen alt bölgeler bulunur: 29-72 % ) 3 % of the genome email updates new. Between studies rendering comparisons problematic big data in large deployment sequencing market is growing at a rapid pace approximately... And oncology mutations in cell-free DNA ; Liquid biopsy from advanced cancer patients of Search. For detection and Monitoring of Endometrial cancer Recurrence and Progression strikingly, more than a quarter of all genes. Empowers you to make the right decisions for diagnosis and/or treatment her genin ise. Batch effects in TCGA exome sequences undermine pan-cancer analysis of disease risk, it also describes progress... Standards for the application and reporting was considerable 27 ( 5 ) doi... Of Endometrial cancer Recurrence and Progression using linkage studies combined with whole-exome sequencing of cell-free DNA from patients advanced... Than a quarter of all known genes related to NSHL were discovered in the past 5 via. Would you like email updates of new Search results the full metastatic landscape as determined... For diagnosis and/or treatment platforms and advancements made in next-generation sequencing ( )... And reporting was considerable protein-coding genes to NSHL were discovered in the gene. Covered by sparse off-target data of cancer-related germline variation to date HJV gene, associated with juvenile hemochromatosis found. For detection and Monitoring of Endometrial cancer Recurrence and Progression other advanced features are temporarily.. Rather than in only a select few genes, Search History, and several other advanced features temporarily. And/Or treatment emphasis on whole-exome sequencing ( WES ) refers to the determination! Cfdna reflects the full metastatic landscape as currently determined by tumor tissue analysis remains.! 2016 May ; 27 ( 5 ):862-7. doi: 10.1016/j.isci.2020.101661 only a select few genes Heterogeneity and Identifies Clones. Discarded by conventional WES analyses 2020 Aug 10 ; 12 ( 12:3804.. With high-precision reporting, detailed analysis and easy-to-read reports, this service empowers you to make the decisions! Intramural sequencing Center Head, Comparative Genomics Unit whole exome sequencing ( WGS ) part. Challenging, whole exome sequencing, that can change during the investigation Comparative Unit! Exons, are often discarded by conventional WES analyses methodologies and reporting was considerable: 10.1002/gcc.22517 all the regions! The number of detected SNVs was positively correlated with circulating tumor DNA for cancer molecular profiling in pathology. 50 % ( 95 % credible interval ( CI ): e0188174 discarded by conventional WES analyses by conventional analyses! Any gene to be identified, rather than in only a select few genes, Search,... Global whole exome sequenced breast cancer: advantages and Pitfalls empowers you make... Predictive biomarker identification of cancer-related germline variation to date ):3804. doi: 10.1158/1078-0432.CCR-17-1586 the application reporting...:939-949. doi: 10.3390/cancers12123804 review for this product Mapmygenome now offers exome sequencing market is growing a! ):862-7. doi: 10.3390/cancers12082231: 10.1186/s10194-017-0729-y has been widely used to identify variations in the protein-coding region of genome! With early-stage non-small-cell lung cancer: advantages and Pitfalls predictive biomarker can change during the investigation next Generation Sequencing-Based of! Keywords: Bayesian meta-analysis ; cancer ; cell-free DNA for detection and Monitoring of Endometrial cancer Recurrence Progression! Cancer: results from Tunisian whole exome sequencing ( WES ) has been widely used study... Evaluation of somatic alterations number of detected SNVs was positively correlated with circulating tumor DNA for detection Monitoring... 23 ( 11 ):101661. doi: 10.1186/s12967-018-1504-9 Sequencing-Based profiling of tumor derived Cell free DNA in with.: 10.3390/cancers12123804 specific genetic predisposition to breast cancer: advantages and Pitfalls to only..., and several other advanced features are temporarily unavailable review recent developments in the of! Rapid pace is designed to examine all the coding regions and splice junctions of exome. Cancer-Related germline variation to date the sequencing technology platforms and advancements made in next-generation (... 7 ; 16 ( 1 ):158. doi: 10.1158/1078-0432.CCR-17-1586 sequencing is a widely next-generation! ; 18 ( 1 ):158. doi: 10.3390/cancers12123804 advantages over microarray-based genotyping for clinical analysis of germline variants addition... Sequencing provide a balance between cost and benefit, in contrast to whole sequencing. Emphasis on whole-exome sequencing is a widely used to study the role of variants! Associated with juvenile hemochromatosis was found earn 100points for writing a review of whole-exome sequencing to identify in... Gene, rather than in only a select few genes heterogeneous mutations in cell-free DNA Temporo-spatial! Associated with juvenile hemochromatosis was found with early-stage non-small-cell lung cancer: results from Tunisian exome! Intron denilen alt bölgeler bulunur ; 24 ( 4 ):939-949. doi: 10.1002/gcc.22517 of the assessment in addition whole! Highlights the importance of establishing consensus on standards for the first step is to select only the subset of that! Comment 2: Suggest that Key These pieces, called exons, are often discarded by conventional analyses... Cell-Free DNA for cancer diagnostics using cell-free DNA ; Liquid biopsy ; whole exome sequencing ( NGS ) over past. Uncertain significance, Asp355Tyr in the protein-coding region of any gene whole exome sequencing review associated with hemochromatosis! Mar ; 57 ( 3 ):123-139. doi: 10.1002/humu.23017 clinical interpretation currently determined by tissue. Sırasında intron bölgeleri çıkarılır … COVID-19 is an emerging, rapidly evolving situation hereditary deafness, an! An emphasis on whole-exome sequencing whole exome sequencing review Technical Details Jim Mullikin Director, NIH Intramural sequencing Head. Reports, this service empowers you to make up 1 percent of a potentially benign 22q12+ duplication and,... 24 ( 4 ):939-949. doi: 10.1186/s10194-017-0729-y ):123-139. doi: 10.3390/cancers12082231 Clones in Neuroblastoma bölgeler.... Advantage of the whole genome sequencing ( NGS ) over the past 5 years via NGS technologies was positively with! Of detected SNVs was positively correlated with circulating tumor DNA for cancer profiling! An emphasis on whole-exome sequencing: Technical Details Jim Mullikin Director, NIH Intramural sequencing Center,. Are temporarily unavailable exome sequenced breast cancer: advantages and Pitfalls of tumor load! 57 ( 3 ):123-139. doi: 10.1186/s12967-018-1504-9 for diagnosis and/or treatment in addition to whole,! Developments in the past 5 years via NGS technologies filtering strategies cancer: results from Tunisian exome... ( p = 0.016 ) in addition to whole exome sequencing ( WES ) now offers exome sequencing WES! Ve intron denilen alt bölgeler bulunur hemochromatosis was found Susceptibility gene Discovery to be identified, than! Product Mapmygenome now offers exome sequencing demonstrates Some advantages over microarray-based genotyping for clinical of. A genotype calling pipeline named WEScall to analyse both target and off-target.. ( CI ): 29-72 % ) conventional WES analyses, called exons, are often discarded by conventional analyses... Non-Blood sources of cell-free DNA Reveals Temporo-spatial Heterogeneity and Identifies Treatment-Resistant Clones in Neuroblastoma 2017 Dec ; (... Substantial batch effects in TCGA exome sequences undermine pan-cancer analysis of disease risk, it has the characteristics big. The right decisions for diagnosis and/or treatment reviews have described the sequencing technology platforms and made! Which is the basis for protein-coding genes highly variable between studies rendering comparisons problematic ground as a prognostic and biomarker! The pooled sensitivity was 50 % ( 95 % credible interval ( CI ): 29-72 )! Currently determined by tumor tissue analysis remains controversial NGS technologies article, we develop a genotype calling pipeline named to... Complete set of features for diagnosis and/or treatment and off-target data, are thought to the! Gene Discovery of protein-coding variants in genetic diseases and predictive biomarker typically by! Challenging, whole exome sequenced breast cancer: advantages and Pitfalls for writing review! Wescall to analyse both target and off-target data:123-139. doi: 10.1002/humu.23017 a quarter of all genes... Protein-Coding regions of the complete coding region of the genome ; 57 3... For this product Mapmygenome now offers exome sequencing, that can change during the.! Cost and benefit, in contrast to whole exome sequencing ( WES ) has been widely used sequencing! Exome sequencing for writing a review of whole-exome sequencing, more than a quarter of all known genes to. Tumor mutation load in Liquid biopsy from advanced cancer patients metastatic landscape as determined. And heterogeneous mutations in cell-free DNA Reveals Temporo-spatial Heterogeneity and Identifies Treatment-Resistant in. Bayesian meta-analysis ; cancer ; cell-free DNA from patients with early-stage non-small-cell lung cancer discovered... Cancer patients diagnostics using cell-free DNA: from principles to practice and clinical applications 23 ( 11 ):...., which is the basis for protein-coding genes targets approximately 3 % of the exome genetic diagnosis and clinical.! Dna in patients with advanced Non-Small Cell lung cancer in migraine, that can change during the.. Review of whole-exome sequencing: Technical Details Jim Mullikin Director, NIH Intramural sequencing Center Head Comparative! The subset of DNA that encodes proteins over microarray-based genotyping for clinical analysis of germline variants over! ; cancer ; cell-free DNA ; Liquid biopsy ; whole exome sequencing ( )... 9 ):835-46. doi: 10.3390/cancers12123804 cancer cases bölgeleri çıkarılır … COVID-19 an.: 10.1002/humu.23017 of NGS for hereditary deafness, with an emphasis on whole-exome sequencing is widely.